Two proteins make mouse heart cells divide after a heart attack
The heart barely recovers after a heart attack. Scar tissue replaces what is lost. Researchers have now identified a combination of two proteins that prompts heart muscle cells in mice to divide again, helping to repair the damage.
Adult heart muscle cells (cardiomyocytes) lose the ability to divide early in development. As a result, the heart cannot replace damaged cells. Earlier work identified the protein Myc as a driver of cell division in regenerative tissues, but Myc alone proved insufficient in the heart. The researchers found that this is because adult cardiomyocytes contain low levels of a protein complex called P-TEFb. P-TEFb is needed to activate RNA polymerase II, the molecular machinery that reads genes to produce proteins. Without enough P-TEFb, Myc cannot do its job.
Temporary boost via messenger RNA
P-TEFb contains a key protein called cyclin T1. When researchers temporarily raised both Myc and cyclin T1 in mouse heart muscle cells, those cells began to divide. They did this using a messenger RNA treatment (mRNA), similar in principle to the technology behind certain vaccines. Both proteins need to be switched on at the same time for the heart muscle cells to start dividing.
Following an experimental heart attack in mice, the treatment led to cell proliferation in the heart muscle and measurable recovery of cardiac function. The study was published in Nature Cardiovascular Research.
From mouse to human: a long road ahead
This is an early study in mice to see whether the idea works. The researchers acknowledge that the delivery system would need to be further developed for a human treatment. Whether it is safe over a longer period has also not yet been tested. Even so, the results point to a possible strategy for helping the heart repair itself in conditions where treatment options are currently limited.
Want to research this yourself?
Search for example:
- cardiomyocyte proliferation cardiac regeneration | Myc P-TEFb transcription cell division | mRNA therapy heart muscle repair